Catalyst Wire Dossier Catalyst Wire Dossier

Qapzola

apaziquone · Spectrum Pharmaceuticals, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Qapzola, covering 2021-09-28 to 2021-09-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) [Phase 3]

See pricing